Genitourinary Disorders
Genitourinary Disorders is a key segment within the Healthcare sector, comprising 611+ companies actively operating in this space.
This segment represents businesses focused on specific activities and services within Healthcare. Companies in this segment share common characteristics, market positioning, and often face similar challenges and opportunities.
Browse the comprehensive directory of Genitourinary Disorders companies to access detailed profiles, financial information, funding rounds, investor details, and other critical business intelligence for research, due diligence, and market analysis.
Discover leading companies in this segment, ranked by company performance and market presence.
Therapeutics for drug-resistant bacterial infections are developed.
Sacral neuromodulation devices are developed for urinary and bowel control.
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction
Therapeutics for infectious and autoimmune diseases are developed.
Miniaturized injectable neuromodulation devices are developed for chronic diseases.
Developer of a therapeutic solution to treat prostate, kidney, and bladder cancer
A device is developed to treat urinary obstruction from BPH.
Minimally invasive devices in urology
Diagnostic devices for lower urinary tract diseases are developed.
Medical device for benign prostatic hyperplasia treatment is developed.
Bioelectrical therapies for peripheral nervous system disorders are developed.
Developer of active implantable devices for urological incontinence
Urological devices for post-prostatectomy incontinence are developed by Levee Medical.
Medical devices for ostomy, urology, and wound care are manufactured.
Developer of antibiotics to treat urinary tract infections and multi-drug resistant infections
Lipid-based therapies for common bladder syndromes are developed.
Catheters for ultrasound-guided drug delivery to the bladder are developed.
Developer of antibiotics for MDR infections
A coin-sized neuromodulation device for hypertension treatment is developed.
Peptide-targeted radiopharmaceuticals for cancer treatment are developed.
Explore Companies in Genitourinary Disorders
Access detailed company profiles, financial data, funding information, and more for all companies in this segment.
View All Companies